Image of drugs on a platform

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to…
Image of a researcher looking through a microscope

PYC achieved protein-restoration on genetic condition PMS ahead of human trialling

Pyc Therapeutics Ltd has successfully restored a protein connected to the Phelan McDermid Syndrome ahead of…